Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Phenethylamine hydrochloride
RN: 156-28-5
UNII: VOF61XW69D
InChIKey: SKHIBNDAFWIOPB-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Human Data
  • Skin / Eye Irritant

Molecular Formula

  • C8-H11-N.Cl-H

Molecular Weight

  • 157.643
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Phenethylamine hydrochloride

Synonyms

  • 1-Phenyl-2-aminoethane hydrochloride
  • 2-Phenylethylamine hydrochloride
  • Benzeneethanamine hydrochloride
  • beta-Phenethylamine hydrochloride
  • beta-Phenylathylaminhydrochlorid
  • beta-Phenylathylaminhydrochlorid [German]
  • beta-Phenylethylamine hydrochloride
  • EINECS 205-849-2
  • NSC 138569
  • Phenethylammonium chloride
  • UNII-VOF61XW69D
  • USAF EL-76

Systematic Names

  • Benzeneethanamine, hydrochloride
  • Benzeneethanamine, hydrochloride (1:1)
  • Phenethylamine, hydrochloride
  • Phenethylammonium chloride

Registry Numbers

CAS Registry Number

  • 156-28-5

FDA UNII

  • VOF61XW69D

Related Registry Number

  • 64-04-0 (Parent)

System Generated Number

  • 0000156285

Molecular Formulas

Molecular Formula

  • C8-H11-N.Cl-H

Molecular Formula Fragments

  • C8-H11-N
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C8H11N.ClH/c9-7-6-8-4-2-1-3-5-8;/h1-5H,6-7,9H2;1H

InChIKey

SKHIBNDAFWIOPB-UHFFFAOYSA-N

Smiles

c1(ccccc1)CCN.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LDLo subcutaneous 316mg/kg (316mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Journal of Pharmacology and Experimental Therapeutics. Vol. 47, Pg. 339, 1933.
guinea pig LDLo subcutaneous 325mg/kg (325mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Journal of Pharmacology and Experimental Therapeutics. Vol. 32, Pg. 121, 1927.
human TDLo oral 714ug/kg (0.714mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION Archives of Internal Medicine. Vol. 39, Pg. 404, 1927.
human TDLo oral 45mg/kg (45mg/kg) BEHAVIORAL: ANOREXIA (HUMAN

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Klinische Wochenscrift. Vol. 17, Pg. 1580, 1938.
mouse LD50 intraperitoneal 146mg/kg (146mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Russian Pharmacology and Toxicology Vol. 39, Pg. 209, 1976.
mouse LD50 intravenous 50mg/kg (50mg/kg)   Annales Pharmaceutiques Francaises. Vol. 9, Pg. 390, 1951.
mouse LD50 oral 400mg/kg (400mg/kg)   Journal of the American Chemical Society. Vol. 63, Pg. 602, 1941.
mouse LD50 subcutaneous 470mg/kg (470mg/kg)   Journal of Pharmacy and Pharmacology. Vol. 15, Pg. 472, 1963.
mouse LDLo unreported 300mg/kg (300mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 8, Pg. 126, 1916.
rabbit LDLo intravenous 50mg/kg (50mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 36, Pg. 363, 1929.
rabbit LDLo subcutaneous 300mg/kg (300mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Archives of Internal Medicine. Vol. 39, Pg. 404, 1927.
rat LDLo subcutaneous 160mg/kg (160mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 71, Pg. 62, 1941.